{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:50:12Z","timestamp":1787313012064,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>CircLRIG1<\/jats:italic>\n                    , a newly discovered circRNA, has yet to have its potential function and biological processes reported. This study explored the role of\n                    <jats:italic>circLRIG1<\/jats:italic>\n                    in the development and progression of bladder carcinoma and its potential molecular mechanisms. Techniques such as qRT-PCR, Western blot, various cellular assays, and in vivo models were used to investigate mRNA and protein levels, cell behavior, molecular interactions, and tumor growth. The results showed that both\n                    <jats:italic>circLRIG1<\/jats:italic>\n                    and\n                    <jats:italic>LRIG1<\/jats:italic>\n                    were significantly reduced in bladder carcinoma tissues and cell lines. Low\n                    <jats:italic>circLRIG1<\/jats:italic>\n                    expression was associated with poor patient prognosis. Overexpressing\n                    <jats:italic>circLRIG1<\/jats:italic>\n                    inhibited bladder carcinoma cell growth, migration, and invasion, promoted apoptosis, and decreased tumor growth and metastasis in vivo. Importantly,\n                    <jats:italic>circLRIG1<\/jats:italic>\n                    was found to sponge\n                    <jats:italic>miR-214-3p<\/jats:italic>\n                    , enhancing\n                    <jats:italic>LRIG1<\/jats:italic>\n                    expression, and its overexpression also modulated protein levels of E-cadherin, N-cadherin, Vimentin, and LRIG1. Similar effects were observed with\n                    <jats:italic>LRIG1<\/jats:italic>\n                    overexpression. Notably, a positive correlation was found between\n                    <jats:italic>circLRIG1<\/jats:italic>\n                    and\n                    <jats:italic>LRIG1<\/jats:italic>\n                    expression in bladder carcinoma tissues. Additionally, the tumor-suppressing effect of\n                    <jats:italic>circLRIG1<\/jats:italic>\n                    was reversed by overexpressing\n                    <jats:italic>miR-214-3p<\/jats:italic>\n                    or silencing\n                    <jats:italic>LRIG1<\/jats:italic>\n                    . The study concludes that\n                    <jats:italic>circLRIG1<\/jats:italic>\n                    suppresses bladder carcinoma progression by enhancing\n                    <jats:italic>LRIG1<\/jats:italic>\n                    expression via sponging\n                    <jats:italic>miR-214-3p<\/jats:italic>\n                    , providing a potential strategy for early diagnosis and treatment of bladder carcinoma.\n                  <\/jats:p>","DOI":"10.1186\/s13062-023-00446-x","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T02:02:34Z","timestamp":1709776954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dysregulation and antimetastatic function of circLRIG1 modulated by miR-214-3p\/LRIG1 axis in bladder carcinoma"],"prefix":"10.1186","volume":"19","author":[{"given":"Shiliang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"446_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71:96\u2013108.","journal-title":"Eur Urol"},{"key":"446_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"446_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, Theodorescu D. Bladder cancer Nat Rev Dis Primers. 2023;9:58.","journal-title":"Bladder cancer Nat Rev Dis Primers"},{"key":"446_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 12","key":"446_CR5","first-page":"87","volume":"83","author":"S Sataa","year":"2005","unstructured":"Sataa S, Yassine N, Ghassen HH, Imed BS, Mohamed C, Maher C, Ali H. Contemporary management of stage T1 transitional cell carcinoma of the bladder. Tunis Med. 2005;83(Suppl 12):87\u20139.","journal-title":"Tunis Med"},{"key":"446_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.euf.2023.03.017","volume":"9","author":"CD Gaffney","year":"2023","unstructured":"Gaffney CD, Katims A, D\u2019Souza N, Bjurlin MA, Matulewicz RS. Bladder cancer carcinogens: opportunities for risk reduction. Eur Urol Focus. 2023;9:575\u20138.","journal-title":"Eur Urol Focus"},{"key":"446_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R, Comperat EM, Cowan NC, Gakis G, Hernandez V, Linares Espinos E, Lorch A, Neuzillet Y, Rouanne M, Thalmann GN, Veskimae E, Ribal MJ, van der Heijden AG. European Association of Urology Guidelines on Muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79:82\u2013104.","journal-title":"Eur Urol"},{"key":"446_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11427-020-1768-y","volume":"64","author":"Z Wu","year":"2021","unstructured":"Wu Z, Liu J, Dai R, Wu S. Current status and future perspectives of immunotherapy in bladder cancer treatment. Sci China Life Sci. 2021;64:512\u201333.","journal-title":"Sci China Life Sci"},{"key":"446_CR9","doi-asserted-by":"publisher","first-page":"47186","DOI":"10.18632\/oncotarget.9706","volume":"7","author":"M Huang","year":"2016","unstructured":"Huang M, Zhong Z, Lv M, Shu J, Tian Q, Chen J. Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma. Oncotarget. 2016;7:47186\u2013200.","journal-title":"Oncotarget"},{"key":"446_CR10","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1038\/ncomms11215","volume":"7","author":"Q Zheng","year":"2016","unstructured":"Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B, Luo Y, Lyu D, Li Y, Shi G, Liang L, Gu J, He X, Huang S. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 2016;7:11215.","journal-title":"Nat Commun"},{"key":"446_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/280339a0","volume":"280","author":"MT Hsu","year":"1979","unstructured":"Hsu MT, Coca-Prados M. Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature. 1979;280:339\u201340.","journal-title":"Nature"},{"key":"446_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003777","volume":"9","author":"J Salzman","year":"2013","unstructured":"Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO. Cell-type specific features of circular RNA expression. PLoS Genet. 2013;9: e1003777.","journal-title":"PLoS Genet"},{"key":"446_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.606485","volume":"10","author":"Z Liang","year":"2020","unstructured":"Liang Z, Guo W, Fang S, Zhang Y, Lu L, Xu W, Qian H. CircRNAs: emerging bladder cancer biomarkers and targets. Front Oncol. 2020;10: 606485.","journal-title":"Front Oncol"},{"key":"446_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C, le Noble F, Rajewsky N. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333\u20138.","journal-title":"Nature"},{"key":"446_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41419-020-2226-5","volume":"11","author":"T Liu","year":"2020","unstructured":"Liu T, Lu Q, Liu J, Xie S, Feng B, Zhu W, Liu M, Liu Y, Zhou X, Sun W, Zhang Y, Chen X, Fang F, Guo H, Yang R. Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating \u2206NP63 by sponging miR-762. Cell Death Dis. 2020;11:47.","journal-title":"Cell Death Dis"},{"key":"446_CR16","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/ddr.21835","volume":"82","author":"W Ye","year":"2021","unstructured":"Ye W, Chen L, Feng C, Liang T. CircMYLK promotes the growth, migration, invasion, and survival of bladder cancer cells by upregulating CCND3 level via competitively binding to miR-34a. Drug Dev Res. 2021;82:1206\u201316.","journal-title":"Drug Dev Res"},{"key":"446_CR17","doi-asserted-by":"crossref","unstructured":"Liang H, Huang H, Li Y, Lu Y, Ye T. CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486\u20133p\/FOXP4 axis. Biosci Rep. 2020;40.","DOI":"10.1042\/BSR20193484"},{"key":"446_CR18","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.7150\/jca.53385","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang J, Liu X, Dai G, Qu L, Tan B, Zhu B, Qi F, Gai X, Cheng B. CircNT5E promotes the proliferation and migration of bladder cancer via sponging miR-502-5p. J Cancer. 2021;12:2430\u20139.","journal-title":"J Cancer"},{"key":"446_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5483\/BMBRep.2020.53.2.059","volume":"53","author":"C Zhuang","year":"2020","unstructured":"Zhuang C, Huang X, Yu J, Gui Y. Circular RNA hsa_circ_0075828 promotes bladder cancer cell proliferation through activation of CREB1. BMB Rep. 2020;53:82\u20137.","journal-title":"BMB Rep"},{"key":"446_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333.","journal-title":"Cell"},{"key":"446_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.eururo.2011.01.044","volume":"59","author":"JW Catto","year":"2011","unstructured":"Catto JW, Alcaraz A, Bjartell AS, De Vere WR, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol. 2011;59:671\u201381.","journal-title":"Eur Urol"},{"key":"446_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/jb\/mvaa134","volume":"169","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zhang L, Chen Q, Qiao S, Zhou F, Han M. LncRNA HEIH promotes cell proliferation, migration and invasion by suppressing miR-214-3p in gastric carcinoma. J Biochem. 2021;169:535\u201342.","journal-title":"J Biochem"},{"key":"446_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12935-021-02103-7","volume":"21","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Wang Y, Lin M, Wu D, Zhao M. LncRNA HOTAIR promotes proliferation and inhibits apoptosis by sponging miR-214-3p in HPV16 positive cervical cancer cells. Cancer Cell Int. 2021;21:400.","journal-title":"Cancer Cell Int"},{"key":"446_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2147\/OTT.S235862","volume":"13","author":"L Yang","year":"2020","unstructured":"Yang L, Zhang L, Lu L, Wang Y. miR-214-3p regulates multi-drug resistance and apoptosis in retinoblastoma cells by targeting ABCB1 and XIAP. Onco Targets Ther. 2020;13:803\u201311.","journal-title":"Onco Targets Ther"},{"key":"446_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jdermsci.2023.06.001","volume":"111","author":"J Ma","year":"2023","unstructured":"Ma J, Huang L, Gao YB, Li MX, Chen LL, Yang L. Circ_TNFRSF21 promotes cSCC metastasis and M2 macrophage polarization via miR-214-3p\/CHI3L1. J Dermatol Sci. 2023;111:32\u201342.","journal-title":"J Dermatol Sci"},{"key":"446_CR26","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s10616-019-00352-z","volume":"71","author":"Y Tao","year":"2019","unstructured":"Tao Y, Zhao Z, Ma J, Dong L, Liang Y, Li S, Mao Y, Li Y, Zhang Y. MiR-214-3p regulates the viability, invasion, migration and EMT of TNBC cells by targeting ST6GAL1. Cytotechnology. 2019;71:1155\u201365.","journal-title":"Cytotechnology"},{"key":"446_CR27","first-page":"2620","volume":"16","author":"H Cai","year":"2018","unstructured":"Cai H, Miao M, Wang Z. miR-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting CADM1. Oncol Lett. 2018;16:2620\u20138.","journal-title":"Oncol Lett"},{"key":"446_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12920-020-00846-2","volume":"14","author":"M Bakherad","year":"2021","unstructured":"Bakherad M, Salimi M, Angaji SA, Mahjoubi F, Majidizadeh T. LRIG1 expression and colorectal cancer prognosis. BMC Med Genom. 2021;14:20.","journal-title":"BMC Med Genom"},{"key":"446_CR29","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1002\/ijc.25820","volume":"128","author":"M Thomasson","year":"2011","unstructured":"Thomasson M, Wang B, Hammarsten P, Dahlman A, Persson JL, Josefsson A, Stattin P, Granfors T, Egevad L, Henriksson R, Bergh A, Hedman H. LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer. Int J Cancer. 2011;128:2843\u201352.","journal-title":"Int J Cancer"},{"key":"446_CR30","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/onc.2013.98","volume":"33","author":"JJ Sheu","year":"2014","unstructured":"Sheu JJ, Lee CC, Hua CH, Li CI, Lai MT, Lee SC, Cheng J, Chen CM, Chan C, Chao SC, Chen JY, Chang JY, Lee CH. LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling. Oncogene. 2014;33:1375\u201384.","journal-title":"Oncogene"},{"key":"446_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00042728-200504000-00008","volume":"31","author":"A Tanemura","year":"2005","unstructured":"Tanemura A, Nagasawa T, Inui S, Itami S. LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases. Dermatol Surg. 2005;31:423\u201330.","journal-title":"Dermatol Surg"},{"key":"446_CR32","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1158\/0008-5472.CAN-13-2112","volume":"74","author":"PA Thompson","year":"2014","unstructured":"Thompson PA, Ljuslinder I, Tsavachidis S, Brewster A, Sahin A, Hedman H, Henriksson R, Bondy ML, Melin BS. Loss of LRIG1 locus increases risk of early and late relapse of stage I\/II breast cancer. Cancer Res. 2014;74:2928\u201335.","journal-title":"Cancer Res"},{"key":"446_CR33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1525-1438.2007.01021.x","volume":"18","author":"AK Lindstrom","year":"2008","unstructured":"Lindstrom AK, Ekman K, Stendahl U, Tot T, Henriksson R, Hedman H, Hellberg D. LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking. Int J Gynecol Cancer. 2008;18:312\u20137.","journal-title":"Int J Gynecol Cancer"},{"key":"446_CR34","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/path.4148","volume":"229","author":"L Lu","year":"2013","unstructured":"Lu L, Teixeira VH, Yuan Z, Graham TA, Endesfelder D, Kolluri K, Al-Juffali N, Hamilton N, Nicholson AG, Falzon M, Kschischo M, Swanton C, Wright NA, Carroll B, Watt FM, George JP, Jensen KB, Giangreco A, Janes SM. LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development. J Pathol. 2013;229:608\u201320.","journal-title":"J Pathol"},{"key":"446_CR35","doi-asserted-by":"crossref","unstructured":"Issue Information-Declaration of Helsinki. J Bone Miner Res. 2018; 33:BM i-BM ii.","DOI":"10.1002\/jbmr.3262"},{"key":"446_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12943-020-01183-9","volume":"19","author":"X Zheng","year":"2020","unstructured":"Zheng X, Huang M, Xing L, Yang R, Wang X, Jiang R, Zhang L, Chen J. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer. 2020;19:73.","journal-title":"Mol Cancer"},{"key":"446_CR37","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41401-020-0374-x","volume":"41","author":"XM Wei","year":"2020","unstructured":"Wei XM, Wumaier G, Zhu N, Dong L, Li CW, Xia JW, Zhang YZ, Zhang P, Zhang XJ, Zhang YY, Li SQ. Protein tyrosine phosphatase L1 represses endothelial-mesenchymal transition by inhibiting IL-1beta\/NF-kappaB\/Snail signaling. Acta Pharmacol Sin. 2020;41:1102\u201310.","journal-title":"Acta Pharmacol Sin"},{"key":"446_CR38","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.2147\/DDDT.S332847","volume":"15","author":"GN He","year":"2021","unstructured":"He GN, Bao NR, Wang S, Xi M, Zhang TH, Chen FS. Ketamine induces ferroptosis of liver cancer cells by targeting lncRNA PVT1\/miR-214-3p\/GPX4. Drug Des Dev Ther. 2021;15:3965\u201378.","journal-title":"Drug Des Dev Ther"},{"key":"446_CR39","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","volume":"58","author":"A Rybak-Wolf","year":"2015","unstructured":"Rybak-Wolf A, Stottmeister C, Glazar P, Jens M, Pino N, Giusti S, Hanan M, Behm M, Bartok O, Ashwal-Fluss R, Herzog M, Schreyer L, Papavasileiou P, Ivanov A, Ohman M, Refojo D, Kadener S, Rajewsky N. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58:870\u201385.","journal-title":"Mol Cell"},{"key":"446_CR40","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s10620-020-06358-4","volume":"66","author":"D Yu","year":"2021","unstructured":"Yu D, Zhang C. Circular RNA PTK2 accelerates cell proliferation and inhibits cell apoptosis in gastric carcinoma via miR-139-3p. Dig Dis Sci. 2021;66:1499\u2013509.","journal-title":"Dig Dis Sci"},{"key":"446_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.602707","volume":"8","author":"Y Mao","year":"2020","unstructured":"Mao Y, Li W, Hua B, Gu X, Pan W, Chen Q, Xu B, Lu C, Wang Z. Circular RNA_PDHX promotes the proliferation and invasion of prostate cancer by sponging MiR-378a-3p. Front Cell Dev Biol. 2020;8: 602707.","journal-title":"Front Cell Dev Biol"},{"key":"446_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.592884","volume":"10","author":"H Ma","year":"2020","unstructured":"Ma H, Huang C, Huang Q, Li G, Li J, Huang B, Zhong Q, Cao C. Circular RNA circ_0014717 suppresses hepatocellular carcinoma tumorigenesis through regulating miR-668-3p\/BTG2 axis. Front Oncol. 2020;10: 592884.","journal-title":"Front Oncol"},{"key":"446_CR43","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12967-018-1593-5","volume":"16","author":"DD Xiong","year":"2018","unstructured":"Xiong DD, Dang YW, Lin P, Wen DY, He RQ, Luo DZ, Feng ZB, Chen G. A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. J Transl Med. 2018;16:220.","journal-title":"J Transl Med"},{"key":"446_CR44","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1080\/15384101.2020.1852746","volume":"19","author":"S Wu","year":"2020","unstructured":"Wu S, Deng H, He H, Xu R, Wang Y, Zhu X, Zhang J, Zeng Q, Zhao X. The circ_0004463\/miR-380-3p\/FOXO1 axis modulates mitochondrial respiration and bladder cancer cell apoptosis. Cell Cycle. 2020;19:3563\u201380.","journal-title":"Cell Cycle"},{"key":"446_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12614","volume":"52","author":"P Liu","year":"2019","unstructured":"Liu P, Li X, Guo X, Chen J, Li C, Chen M, Liu L, Zhang X, Zu X. Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1\/hsa-miR-132-3p\/Sox5 signalling pathway. Cell Prolif. 2019;52: e12614.","journal-title":"Cell Prolif"},{"key":"446_CR46","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s10020-018-0039-0","volume":"24","author":"Z Wu","year":"2018","unstructured":"Wu Z, Huang W, Wang X, Wang T, Chen Y, Chen B, Liu R, Bai P, Xing J. Circular RNA CEP128 acts as a sponge of miR-145-5p in promoting the bladder cancer progression via regulating SOX11. Mol Med. 2018;24:40.","journal-title":"Mol Med"},{"key":"446_CR47","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234:5451\u201365.","journal-title":"J Cell Physiol"},{"key":"446_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1756-9966-32-101","volume":"32","author":"L Chang","year":"2013","unstructured":"Chang L, Shi R, Yang T, Li F, Li G, Guo Y, Lang B, Yang W, Zhuang Q, Xu H. Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity. J Exp Clin Cancer Res. 2013;32:101.","journal-title":"J Exp Clin Cancer Res"},{"key":"446_CR49","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3892\/or.2015.3807","volume":"33","author":"Z Yan","year":"2015","unstructured":"Yan Z, Jiang J, Li F, Yang W, Xie G, Zhou C, Xia S, Cheng Y. Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin. Oncol Rep. 2015;33:1791\u20138.","journal-title":"Oncol Rep"},{"key":"446_CR50","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1464-410X.2006.06405.x","volume":"98","author":"WM Yang","year":"2006","unstructured":"Yang WM, Yan ZJ, Ye ZQ, Guo DS. LRIG1, a candidate tumour-suppressor gene in human bladder cancer cell line BIU87. BJU Int. 2006;98:898\u2013902.","journal-title":"BJU Int"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-023-00446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-023-00446-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-023-00446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T07:02:46Z","timestamp":1710054166000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-023-00446-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["446"],"URL":"https:\/\/doi.org\/10.1186\/s13062-023-00446-x","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"12 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of Shanghai Eastern Hepatobiliary Surgery Hospital, and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients in this study provided their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}